Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
Vadim Pivniouk, Oksana Pivniouk, Avery DeVries, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 923-933.e6
Open Access | Times Cited: 25

Showing 25 citing articles:

The Current and Future Perspectives of Postbiotics
Bing Liang, Dongming Xing
Probiotics and Antimicrobial Proteins (2023) Vol. 15, Iss. 6, pp. 1626-1643
Open Access | Times Cited: 92
Microbiota and COVID-19: Long-term and complex influencing factors
Jiaqi Gang, Haiyu Wang, Xiangsheng Xue, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 48
The Prevalence and Impact of Coinfection and Superinfection on the Severity and Outcome of COVID-19 Infection: An Updated Literature Review
Samya A. Omoush, Jihad A. M. Alzyoud
Pathogens (2022) Vol. 11, Iss. 4, pp. 445-445
Open Access | Times Cited: 35
Viral Infection and Airway Epithelial Immunity in Asthma
So Ri Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9914-9914
Open Access | Times Cited: 24
Bifidobacterium pseudolongum‐Derived Bile Acid from Dietary Carvacrol and Thymol Supplementation Attenuates Colitis via cGMP‐PKG‐mTORC1 Pathway
Ke Zhang, Yangbin Xu, Yining Zheng, et al.
Advanced Science (2024)
Open Access | Times Cited: 5
Modulation of innate immunity in airway epithelium for host-directed therapy
Iwona T. Myszor, Guðmundur H. Guðmundsson
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Advances in Bacterial Lysate Immunotherapy for Infectious Diseases and Cancer
Md. Mijanur Rahman, I. Darren Grice, Glen C. Ulett, et al.
Journal of Immunology Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 4
Postbiotics and Kidney Disease
Chiara Favero, Laura Giordano, Silvia M. Mihăilă, et al.
Toxins (2022) Vol. 14, Iss. 9, pp. 623-623
Open Access | Times Cited: 19
Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
Krist Helen Antunes, Gisele Cassão, Leonardo Duarte Santos, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Sublingually administered bacterial lysates: rationale, mechanisms of action and clinical outcomes
Fulvio Braido, Giovanni Melioli, Gabriele Nicolini, et al.
Drugs in Context (2024) Vol. 13, pp. 1-9
Open Access | Times Cited: 3
Oral Bacterial Lysate OM-85: Advances in Pharmacology and Therapeutics
Lingling Zhu, Yanhong Wang, Jianhua Feng, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4387-4399
Open Access | Times Cited: 3
Bacterial lysate add-on therapy in adult and childhood asthma: a systematic review and meta-analysis
Siyang Yao, Rundong Qin, Xiaonan Song, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 6, pp. 3143-3157
Open Access | Times Cited: 7
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease
Ashley Fraser, Phillippa Poole
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 10
Can bacterial lysates be useful in prevention of viral respiratory infections in childhood? The results of experimental OM-85 studies
Stefania Ballarini, Ledit Ardusso, José António Ortega Martell, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 10
European Respiratory Society Research Seminar on Preventing Pediatric Asthma
Jonathan Grigg, Benjamin Barratt, Klaus Bønnelykke, et al.
Pediatric Pulmonology (2024)
Closed Access | Times Cited: 1
Exogenous Chemical Exposure Increased Transcription Levels of the Host Virus Receptor Involving Coronavirus Infection
Xiaoting Jin, Jingxu Zhang, Yanting Li, et al.
Environmental Science & Technology (2022) Vol. 56, Iss. 3, pp. 1854-1863
Closed Access | Times Cited: 4
The OM-85 bacterial lysate: A new tool against SARS-CoV-2?
Vadim Pivniouk, Donata Vercelli
Multidisciplinary Respiratory Medicine (2023) Vol. 18
Open Access | Times Cited: 2
The effectiveness of a polyvalent antigenic complex including bacterial lysates in the treatment and prevention of rhinosinusitis against the background of acute respiratory viral infections and COVID-19 (clinical description)
А. А. Кривопалов, S. V. Ryazantsev, Yu. S. Aleksanian, et al.
Meditsinskiy sovet = Medical Council (2023), Iss. 7, pp. 52-62
Open Access | Times Cited: 1
Is There a Role for Immunostimulant Bacterial Lysates in the Management of Respiratory Tract Infection?
Mario Di Gioacchino, Francesca Santilli, Andrea Pession
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1249-1249
Open Access
Evaluating microbial products as potential SARS-CoV-2 inhibitors
Shreynish Joy Mawooa, Hema Bikoo, Yojna Chumrah, et al.
Elsevier eBooks (2024), pp. 265-295
Closed Access
The SARS-CoV-2 cellular receptor ACE2 is expressed in oropharyngeal cells and is modulated in vitro by the bacterial lysate Lantigen B
Caterina Pizzimenti, Antonella D’Agostino, Paola Pirrello, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
OM-85 reduces SARS-COV-2 viral RNA expression in nasopharyngeal cells from COVID-19 patients
Gisele Cassão, Krist Helen Antunes, João Ismael Budelon Gonçalvez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Can Ursodeoxycholic Acid Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Reduce the Coronavirus Disease 2019 Severity? Current Knowledge and Unresolved Issues
Shida Pan, Yang Zhang, Fanping Meng, et al.
Infectious Diseases & Immunity (2023)
Open Access
Brief research report: OM-85 reduces SARS-COV-2 viral RNA expression in nasopharyngeal cells from COVID-19 patients
Gisele Cassão, Krist Helen Antunes, João Ismael Budelon Gonçalvez, et al.
Frontiers in Virology (2023) Vol. 3
Open Access
Modulating the Expression of Multiple Surface Receptors on Epithelial Cells and Promoting Lung Macrophage Anti-viral Functions by OM-85 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Niki Ubags, Christophe von Garnier
EMJ Respiratory (2022), pp. 67-76
Open Access
Page 1

Scroll to top